IceCure Medical Ltd. ICCM stock fell more than 10% during Friday’s session. On Thursday, the company said it has regained ...
IceCure reported a 70% increase in its active U.S. commercial install base of ProSense systems.
IceCure Medical Ltd. ICCM shares are soaring Wednesday after the company reported a 70% jump in its U.S. commercial install ...
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
IceCure Medical (Nasdaq: ICCM) stock surges on news of a 70% increase in its U.S. active commercial install base of ...
Purchase funded by the Thomas Foundation following FDA marketing authorization of ProSense(R) in low-risk breast cancer and inclusion of cryoablation in proposed medical society guidelines CAESAREA, ...
CAESAREA, Israel, Feb. 15, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that ...
IceCure Medical (ICCM) announced the FDA’s Medical Device Advisory Committee Panel’s favorable recommendation with 9 panelists voting in favor and 5 voting against the benefit-risk profile of ...
One of the biggest frustrations with GPS running watches has always been battery life. These devices are great for recording workout data, but with satellite tracking turned on they can run out of ...
At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors ≤3 cm and 83.9% of patients remained ...